PAD4 (human recombinant)

PAD4 (human recombinant) Suppliers list
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Products Intro: Product Name:PAD4 (human, recombinant; His- and GST-tagged)
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
Company Name: Shanghai Universal Biotech Co.,Ltd  
Tel: 18768175414
Email: gaojun@univ-bio.com
Products Intro: Product Name:PAD4 (human, recombinant)
Package:100ug,1mg Remarks: 见优宁维官网
Company Name: Shanghai Jijin Chemical Technology Co., Ltd.  
Tel: 400-002-6926 15900443528
Email: jijinhuaxue@sina.com
Products Intro: Product Name:PAD4 (human recombinant)
Company Name: Morning Student Science and Technology (Guangzhou) Co., Ltd.  
Tel: 020-36048871 13760856740
Email: chenxue_gz@163.com
Products Intro: Product Name:PAD4 (human recombinant)
Company Name: Shanghai Hao Zhun Biological Technology Co., Ltd.  
Tel: 15800340161
Email: info@zzsrm.com
Products Intro: Product Name:PAD4 (human recombinant)
PAD4 (human recombinant) Basic information
Product Name:PAD4 (human recombinant)
Synonyms:PAD4 (human recombinant);His- and GST-tagged)
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
PAD4 (human recombinant) Structure
PAD4 (human recombinant) Chemical Properties
Safety Information
MSDS Information
PAD4 (human recombinant) Usage And Synthesis
DescriptionProtein arginine deiminase 4 (PAD4) catalyzes the conversion of arginine residues to citrulline within cellular protein substrates, resulting in the loss of a positive charge, which can alter protein structure and/or function. It is expressed in neutrophils, as well as a variety of tissues, including the brain, liver, lung, and kidney. PAD4 has a key role in NETosis, a lytic form of cell death characterized by the release of neutrophil extracellular traps (NETs). Upon neutrophil activation, PAD4 translocates to the nucleus where it citrullinates histones, initiating chromatin decondensation and the release of NETs. Neutrophils isolated from Pad4-/- mice exhibit decreased citrullination of histone H3 under both basal and LPS-stimulated conditions and are defective for NET formation in response to stimulation with LPS, phorbol 12-myristate 13-acetate (PMA; ), or hydrogen peroxide. Pad4-/- mice exhibit larger lesions than wild-type mice in a model of necrotizing fasciitis induced by M1 group A S. pyogenes lacking the extracellular DNase Sda1. Pad4-deficient mice also exhibit reduced infarct size in a model of myocardial ischemia-reperfusion injury and reduced tumor growth in a Lewis lung carcinoma model. PADI4 SNPs, including G55S, V82A, and G112A, are associated with rheumatoid arthritis in humans. Cayman’s PAD4 (human, recombinant) protein contains the G55S, V82A, and G112A SNPs and can be used for enzyme activity assays.
PAD4 (human recombinant) Preparation Products And Raw materials
Tag:PAD4 (human recombinant) Related Product Information